Exact Mass: 725.3539946000001

Exact Mass Matches: 725.3539946000001

Found 40 metabolites which its exact mass value is equals to given mass value 725.3539946000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

3-Formyl Rifamycin

26-formyl-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1^{4,7}.0^{5,28}]triaconta-1(28),2,4,9,19,21,25(29),26-octaen-13-yl acetate

C38H47NO13 (725.3047252)


   

Dalargin

2-{2-[2-(2-{2-[2-amino-3-(4-hydroxyphenyl)propanamido]propanamido}acetamido)-3-phenylpropanamido]-4-methylpentanamido}-5-[(diaminomethylidene)amino]pentanoic acid

C35H51N9O8 (725.3860406)


   

2-Deacetylaustrotaxine

2-Deacetylaustrotaxine

C39H51NO12 (725.3411086)


   
   
   

7,9-O-diacetyltaxine A

7,9-O-diacetyltaxine A

C39H51NO12 (725.3411086)


   

14-O-acetyl-8-O-methyl-18-O-2-(2-methyl-4-oxo-4H-quinazoline-3-yl)benzoylcammaconine

14-O-acetyl-8-O-methyl-18-O-2-(2-methyl-4-oxo-4H-quinazoline-3-yl)benzoylcammaconine

C42H51N3O8 (725.3675966000001)


   

3-Formyl Rifamycin

3-formyl Rifamycin SV

C38H47NO13 (725.3047252)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins relative retention time with respect to 9-anthracene Carboxylic Acid is 1.493 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.492

   

3-Formylrifampin

3-Formyl Rifamycin

C38H47NO13 (725.3047252)


   

(D-Ala2)-leucine enkephalin-arg

(D-Ala2)-Leu-Enkephalin-Arg trifluoroacetate salt

C35H51N9O8 (725.3860406)


Dalargin is a potent δ-opioid receptor agonist. Dalargin mitigates Gentamicin (HY-A0276)-induced cell death. Dalargin shows nephroprotective effects on Gentamicin (HY-A0276A)-induced kidney injury. Dalargin shows antiulcer activity[1][2][3]. Dalargin is a potent δ-opioid receptor agonist. Dalargin mitigates Gentamicin (HY-A0276)-induced cell death. Dalargin shows nephroprotective effects on Gentamicin (HY-A0276A)-induced kidney injury. Dalargin shows antiulcer activity[1][2][3].

   

24-demethoxycarbonyl-24-methylstreptovaricin C

24-demethoxycarbonyl-24-methylstreptovaricin C

C39H51NO12 (725.3411086)


   

3,15,27-Triamino-7,19-dihydroxy-10,22,34-trimethyl-31-oxido-1,13,25-trioxa-7,19,31-triazacyclohexatriaconta-9,21,33-triene-2,8,14,20,26,32-hexone

3,15,27-Triamino-7,19-dihydroxy-10,22,34-trimethyl-31-oxido-1,13,25-trioxa-7,19,31-triazacyclohexatriaconta-9,21,33-triene-2,8,14,20,26,32-hexone

C33H53N6O12- (725.3721278)


   

[(9Z,19Z,21Z)-26-formyl-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate

[(9Z,19Z,21Z)-26-formyl-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate

C38H47NO13 (725.3047252)


   

(3S,3S,4R,6S,8R,8aR)-5-[2-(1-hydroxycycloheptyl)ethynyl]-6-[4-(2-hydroxyethoxy)phenyl]-1,2-dioxo-3,4-diphenyl-8-spiro[1H-indole-3,7-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxamide

(3S,3S,4R,6S,8R,8aR)-5-[2-(1-hydroxycycloheptyl)ethynyl]-6-[4-(2-hydroxyethoxy)phenyl]-1,2-dioxo-3,4-diphenyl-8-spiro[1H-indole-3,7-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxamide

C44H43N3O7 (725.3100847999999)


   

[(2R,3S,4S,5S,6R)-2-[[(1R,3S,9R,10S,13R,15E,17E,19E,21E,23R,25S,26R,27S)-26-carbamoyl-1,3,9,27-tetrahydroxy-10,13-dimethyl-7,11-dioxo-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraen-23-yl]oxy]-3,5-dihydroxy-6-methyloxan-4-yl]azanium

[(2R,3S,4S,5S,6R)-2-[[(1R,3S,9R,10S,13R,15E,17E,19E,21E,23R,25S,26R,27S)-26-carbamoyl-1,3,9,27-tetrahydroxy-10,13-dimethyl-7,11-dioxo-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraen-23-yl]oxy]-3,5-dihydroxy-6-methyloxan-4-yl]azanium

C36H57N2O13+ (725.3860452)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

2-{[13-(4-hydroxy-5,6-dimethoxy-3-methylpyridin-2-yl)-3,5,11-trimethyltrideca-2,6,8,11-tetraen-4-yl]oxy}-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

2-{[13-(4-hydroxy-5,6-dimethoxy-3-methylpyridin-2-yl)-3,5,11-trimethyltrideca-2,6,8,11-tetraen-4-yl]oxy}-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C36H55NO14 (725.362237)